Akèy › Metiyè › Natural Sciences Managers › San Francisco, CA
Natural Sciences Managers nan San Francisco, CA: Salè H-1B
27 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan San Francisco, CA. Salè baz medyàn ofri $218,500; mwatye mitan $109,366–$250,000.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $131,248 |
| Nivo II (kalifye) | $109,366 |
| Nivo III (eksperyans) | $248,082 |
| Nivo IV (plen kompetans) | $289,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| University of California, San Francisco | 4 | $95,296 |
| The J. David Gladstone Institutes | 3 | $109,366 |
| Parker Institute for Cancer Immunotherapy | 3 | $250,000 |
| Syneos Health US, Inc. | 2 | $256,350 |
| Nuvation Bio Inc | 2 | $370,000 |
| Astellas Pharma Global Development, Inc. | 1 | $131,914 |
| Alliance for Sustainable Energy, LLC | 1 | $76,000 |
| Vector Oncology, LLC | 1 | $174,158 |
| FibroGen, Inc. | 1 | $130,582 |
| The Smith-Kettlewell Eye Research Institute | 1 | $72,696 |
| PPD Development, L.P. | 1 | $233,210 |
| 89Bio, Inc. | 1 | $273,250 |
| Olema Pharmaceuticals, Inc. | 1 | $218,500 |
| Redwood Materials, Inc. | 1 | $215,000 |
| Truveta, Inc. | 1 | $249,000 |
| Aligos Therapeutics, Inc. | 1 | $248,082 |
| Lila Sciences, Inc. | 1 | $248,082 |
| Genentech, Inc. | 1 | $291,304 |
Tit travay
- Research Director3
- Senior Clinical Research Coordinator3
- Vice President, Clinical Operations2
- Assistant Investigator1
- Senior Manager, CPED Oncology [20357.321.8]1
- Project Manager II - Research1
- Scientific Program Leader I1
- Clinical Research Analyst 41
- Director, Outcomes Science and Services1
- Director, FSC Solution Design1
- Clinical Trial Manager1
- Director - Consulting1
- Research Coordinator1
- Medical Director1
- Senior Medical Director of Drug Safety and Pharmacovigilance1
Pwonse H-1B nan San Francisco, CA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).